hydroxyindoleacetic acid has been researched along with Myasthenia Gravis in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wroe, SJ | 1 |
| Ardron, M | 1 |
| Bowden, AN | 1 |
1 other study available for hydroxyindoleacetic acid and Myasthenia Gravis
| Article | Year |
|---|---|
Myasthenia gravis associated with a hormone producing malignant carcinoid tumour.
Topics: Aged; Carcinoid Tumor; Diagnosis, Differential; Humans; Hydroxyindoleacetic Acid; Ileal Neoplasms; M | 1985 |